Tampere – Finland’s Most Desirable City to Live in – Attracts Tech Talent From Europe
10.8.2023 21:46:00 EEST | Business Wire | Press release
Nestled in the world's happiest country, Tampere, a forward-thinking city, look towards Europe for skilled tech professionals and startup entrepreneurs. Tampere’s International House is hosting an online hackathon-style recruitment event, titled Game On!, on 14–15 September. As part of the hackathon, Tampere is inviting 12 applicants to experience the true Tampere lifestyle.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230810179331/en/
Tampere has a strong tech community and active ecosystems for example in machine learning, imaging, mobile and manufacturing technologies. (Photo: Business Wire)
Tampere is a city known for its courage to grow and go forward. Located in the heart of Finland, Tampere is home to blooming tech companies such as Valmet, Treon, and Colossal Order. Unlike the tech industry in many crowded cities, these tech companies can offer their employees an escape from the chaos and a lifestyle with affordable, easy-access housing and a high standard of living.
Tampere has a strong tech community and active ecosystems for example in machine learning, imaging, mobile and manufacturing technologies. The growing city and its tech industry need bright new tech minds. In the Experience Tampere campaign, European professionals are especially targeted.
Twelve of the tech professionals and startup founders who register for the event by 16 August also have a chance to win a five-day immersive experience in Tampere. There will be a versatile programme for both talents and startup owners coming to experience the hidden gem of Finland between the 12th and 16th of September.
"It will be a unique experience and an opportunity for the winners to meet the companies, get to know the city, its tech scene, and the lifestyle. Tampere will show that high tech can be combined with a vibrant community and chill sauna evenings by beautiful lakeside scenery," says Sini Vilppula, Vice President, Human Resources, at Automation System Business Line in Valmet.
For startup founders, the city organizes a programme where they get to explore the Startup Tampere ecosystem, visit co-working spaces, innovation centers, and accelerators, and feel the energy of the Platform 6 Startup House. Furthermore, connect with local startups, network with founders, gain insights from industry experts, and create new possibilities for their startups.
All participants get to experience Finnish culture with their families and discover the unique charm of Tampere, enjoy cultural activities, indulge in traditional Finnish cuisine, and build connections beyond business.
Further information:
Experience Tampere - International House Tampere
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230810179331/en/
Contact information
Marketing Specialist
Tiia Heikkilä
tiia.heikkila@tampere.fi
+358 41 730 2921
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 12:47:00 EEST | Press release
Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food products. Within this inspiring premise, Good Food Makers confirms itself as one of the main levers f
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 11:16:00 EEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 09:00:00 EEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 09:00:00 EEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom